Medpharm: Abbott Labs buys Guidant vascular biz for $4.1B

Adjust font size:

Increase font size Decrease font size

Medpharm: Abbott Labs buys Guidant vascular biz for $4.1B

Abbott Laboratories has completed its $4.1 billion purchase of Guidant Corp.'s vascular business from Guidant's new parent, Boston Scientific.

Abbott will pay Boston Scientific $250 million when the FDA approves Guidant's drug-eluting stent, and $250 million more upon approval by regulators in Japan for sale of the stent there.

Abbott will absorb 4,000 Guidant employees.

Abbott has also bought about 64 million shares of Boston Scientific stock, and floated Boston Scientific a $900 million five-year interest-bearing loan.

Comments on this story

no comments yet...

click here to add a comment

You must be registered & logged in to add comments
Please register

already have an account and just want to login?

email address
password
remember me
 

Related Content

Boeing Celebrates the Premiere of the 787 Dreamliner
EVERETT, Wash., July 08, 2007 -- Today, Boeing...
more…